Literature DB >> 25093091

The SNPs (-1654C/T, -1641A/G and -1476A/T) of protein C promoter are associated with susceptibility to pulmonary thromboembolism in a Chinese population.

Changtai Zhu1, Ting Jiang1, Yafang Miao1, Sugang Gong1, Kebin Cheng1, Jian Guo1, Xiaoyue Tan1, Jun Yue1, Jinming Liu1.   

Abstract

BACKGROUND: Pulmonary thromboembolism (PTE) is a common and potentially lethal disease. It is significant to investigate the gene mutations of protein C for clarifying the etiology of PTE. In this present study, we investigated the promoter region polymorphism sites including -1654C/T, -1641A/G and -1476A/T of the protein C gene in a Chinese population.
METHODS: A total of 110 cases of PTE and one hundred and ninety healthy controls in a Chinese population were genotyped for three polymorphisms (-1654C/T, -1641A/G and -1476A/T) of the protein C promoter. The statistical analysis was performed by Stata 11.0.
RESULTS: The single nucleotide polymorphisms (SNPs) (-1654C/T, -1641A/G and -1476A/T) in protein C gene were associated with the susceptibility to PTE in Chinese population. According to the binary logistic regression analysis, the independently significant risk factors for PTE were the complications of deep vein thrombosis (DVT) or cancer, history of operation or injury, and the homozygous carriers of the TT genotype (protein C -1654C/T).
CONCLUSIONS: The SNPs (-1654C/T, -1641A/G and -1476A/T) of protein C promoter gene are associated with the susceptibility to PTE in a Chinese population. Especially, the homozygous carriers of genotype TT (-1654C/T) increase the risk of PTE in a Chinese population. Confirmation of our preliminary observations in a larger scale study is needed.

Entities:  

Keywords:  Single nucleotide polymorphisms (SNPs); a Chinese population; protein C; pulmonary thromboembolism (PTE)

Year:  2014        PMID: 25093091      PMCID: PMC4120173          DOI: 10.3978/j.issn.2072-1439.2014.06.30

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  30 in total

1.  Arg506Gln mutation of the coagulation factor V gene not detected in Japanese pulmonary thromboembolism.

Authors:  T Seki; H Okayama; T Kumagai; N Kumasaka; M Sakuma; S Isoyama; K Shirato; H Odaka
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

2.  The factor V Leiden mutation and the prothrombin G20210A mutation was not found in Japanese patients with pulmonary thromboembolism.

Authors:  A Ro; M Hara; A Takada
Journal:  Thromb Haemost       Date:  1999-12       Impact factor: 5.249

3.  The role of angiotensin-converting enzyme gene polymorphism in pulmonary thromboembolism.

Authors:  Numan Ekim; I Kivilcim Oguzulgen; Nalan Demir; Buket Altinok; Nejat Akar
Journal:  Thromb Haemost       Date:  2004-08       Impact factor: 5.249

4.  Gene analysis of heterozygous protein C deficiency in a patient with pulmonary arterial thromboembolism.

Authors:  A Ohwada; H Takahashi; K Uchida; T Nukiwa; S Kira
Journal:  Am Rev Respir Dis       Date:  1992-06

5.  Determination of the allelic and haplotype frequencies of three polymorphisms in the promoter region of the human protein C gene.

Authors:  C A Spek; S R Poort; R M Bertina; P H Reitsma
Journal:  Blood Coagul Fibrinolysis       Date:  1994-04       Impact factor: 1.276

6.  [Pulmonary thromboembolism in a female with resistance to activated protein C].

Authors:  A Ribeiro; A Correia; F Fernandes; A P Barbosa; L Basto; F Lima; P Rodrigues
Journal:  Rev Port Cardiol       Date:  1999-06       Impact factor: 1.374

7.  Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population.

Authors:  Yanhui Lu; Yanfen Zhao; Guozhang Liu; Xiaoling Wang; Zhihong Liu; Baiping Chen; Rutai Hui
Journal:  Thromb Res       Date:  2002-04-01       Impact factor: 3.944

8.  The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.

Authors:  I Kivilcim Oguzulgen; E Yilmaz; Senay Demirtas; Ferda Oner Erkekol; Numan Ekim; Nalan Demir; Numan Numanoglu; Duygu Ozel; Arzu Ulu; Nejat Akar
Journal:  Clin Appl Thromb Hemost       Date:  2007-12-26       Impact factor: 2.389

Review 9.  Comprehensive analysis of the results of the PIOPED Study. Prospective Investigation of Pulmonary Embolism Diagnosis Study.

Authors:  D F Worsley; A Alavi
Journal:  J Nucl Med       Date:  1995-12       Impact factor: 10.057

10.  Physical inactivity and idiopathic pulmonary embolism in women: prospective study.

Authors:  Christopher Kabrhel; Raphaëlle Varraso; Samuel Z Goldhaber; Eric Rimm; Carlos A Camargo
Journal:  BMJ       Date:  2011-07-04
View more
  2 in total

1.  PROC Promoter Single Nucleotide Polymorphisms Associated With Low Protein C Activity But Not Increased Risk of Thromboembolism in Pediatric Population.

Authors:  Natsumon Udomkittivorakul; Werasak Sasanakul; Jakris Eu-Ahsunthornwattana; Ampaiwan Chuansumrit; Patcharee Komwilaisak; Duantida Songdej; Nongnuch Sirachainan
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

2.  MiR-124 and miR-506 are involved in the decline of protein C in children with extra-hepatic portal vein obstruction.

Authors:  Jin-Shan Zhang; Long Li
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.